Terms: = Pancreatic cancer AND ATR, Q13535, 545, ENSG00000175054, MEC1, SCKL, SCKL1, FRP1 AND Prognosis
19 results:
1. Undifferentiated Carcinoma with Osteoclast-like Giant Cells of the Pancreas: Molecular Genetic Analysis of 13 Cases.
Hrudka J; Kalinová M; Ciprová V; Moravcová J; Dvořák R; Matěj R
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542259
[TBL] [Abstract] [Full Text] [Related]
2. Preclinical Synergistic Combination Therapy of Lurbinectedin with Irinotecan and 5-Fluorouracil in pancreatic cancer.
Tummala T; Sevilla Uruchurtu AS; Cruz A; Huntington KE; George A; Liguori NR; Zhang L; Zhou L; Abbas AE; Azzoli CG; El-Deiry WS
Curr Oncol; 2023 Oct; 30(11):9611-9626. PubMed ID: 37999116
[TBL] [Abstract] [Full Text] [Related]
3. Outcomes of lung oligometastasis in pancreatic cancer.
Takeda T; Sasaki T; Ichinose J; Inoue Y; Okamoto T; Mie T; Furukawa T; Kasuga A; Oba A; Matsuura Y; Nakao M; Ozaka M; Mun M; Takahashi Y; Sasahira N
Jpn J Clin Oncol; 2023 Dec; 53(12):1144-1152. PubMed ID: 37609670
[TBL] [Abstract] [Full Text] [Related]
4. Clinical impact of lactate on postoperative pancreatic fistula after pancreaticoduodenectomy: A single-center retrospective study of 1,043 patients.
Yu B; Park CM; Gil E; Yoo K; Choi KJ; Yoon SJ; Han IW
Pancreatology; 2023 Apr; 23(3):245-250. PubMed ID: 36805104
[TBL] [Abstract] [Full Text] [Related]
5. Postoperative hyperprogression disease of pancreatic ductal adenocarcinoma after curative resection: a retrospective cohort study.
Zou S; Wang X; Chen H; Lin J; Wen C; Zhan Q; Chen H; Lu X; Deng X; Shen B
BMC Cancer; 2022 Jun; 22(1):649. PubMed ID: 35698045
[TBL] [Abstract] [Full Text] [Related]
6. Pre-operative radiomics model for prognostication in resectable pancreatic adenocarcinoma with external validation.
Healy GM; Salinas-Miranda E; Jain R; Dong X; Deniffel D; Borgida A; Hosni A; Ryan DT; Njeze N; McGuire A; Conlon KC; Dodd JD; Ryan ER; Grant RC; Gallinger S; Haider MA
Eur Radiol; 2022 Apr; 32(4):2492-2505. PubMed ID: 34757450
[TBL] [Abstract] [Full Text] [Related]
7. Inhibitor library screening identifies ispinesib as a new potential chemotherapeutic agent for pancreatic cancers.
Murase Y; Ono H; Ogawa K; Yoshioka R; Ishikawa Y; Ueda H; Akahoshi K; Ban D; Kudo A; Tanaka S; Tanabe M
Cancer Sci; 2021 Nov; 112(11):4641-4654. PubMed ID: 34510663
[TBL] [Abstract] [Full Text] [Related]
8. CD147 promotes DNA damage response and gemcitabine resistance via targeting ATM/atr/p53 and affects prognosis in pancreatic cancer.
Zhou Y; Zheng M; Liu Z; Yang H; Zhu P; Jiang JL; Tang J; Chen ZN
Biochem Biophys Res Commun; 2020 Jul; 528(1):62-70. PubMed ID: 32456796
[TBL] [Abstract] [Full Text] [Related]
9. Alternative lengthening of telomeres (ALT) influences survival in soft tissue sarcomas: a systematic review with meta-analysis.
Lawlor RT; Veronese N; Pea A; Nottegar A; Smith L; Pilati C; Demurtas J; Fassan M; Cheng L; Luchini C
BMC Cancer; 2019 Mar; 19(1):232. PubMed ID: 30871494
[TBL] [Abstract] [Full Text] [Related]
10. Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Zhu AX; Kang YK; Yen CJ; Finn RS; Galle PR; Llovet JM; Assenat E; Brandi G; Pracht M; Lim HY; Rau KM; Motomura K; Ohno I; Merle P; Daniele B; Shin DB; Gerken G; Borg C; Hiriart JB; Okusaka T; Morimoto M; Hsu Y; Abada PB; Kudo M;
Lancet Oncol; 2019 Feb; 20(2):282-296. PubMed ID: 30665869
[TBL] [Abstract] [Full Text] [Related]
11. Targeting Defects in the Cellular DNA Damage Response for the Treatment of pancreatic Ductal Adenocarcinoma.
Schmitt A; Feldmann G; Zander T; Reinhardt HC
Oncol Res Treat; 2018; 41(10):619-625. PubMed ID: 30286473
[TBL] [Abstract] [Full Text] [Related]
12. Overexpression of S100A4 protein may be associated with the development and progression of pancreatic cancer.
Zhou Y; Li Z; Ding Y; Zhang J; Yang Q; Wu Y
J Cancer Res Ther; 2018; 14(Supplement):S159-S166. PubMed ID: 29578167
[TBL] [Abstract] [Full Text] [Related]
13. Inhibition of atr potentiates the cytotoxic effect of gemcitabine on pancreatic cancer cells through enhancement of DNA damage and abrogation of ribonucleotide reductase induction by gemcitabine.
Liu S; Ge Y; Wang T; Edwards H; Ren Q; Jiang Y; Quan C; Wang G
Oncol Rep; 2017 Jun; 37(6):3377-3386. PubMed ID: 28440428
[TBL] [Abstract] [Full Text] [Related]
14. Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer.
Yang SH; Kuo TC; Wu H; Guo JC; Hsu C; Hsu CH; Tien YW; Yeh KH; Cheng AL; Kuo SH
World J Gastroenterol; 2016 Aug; 22(32):7275-88. PubMed ID: 27621574
[TBL] [Abstract] [Full Text] [Related]
15. Extent of lymphadenectomy to associate with pancreaticoduodenectomy in patients with pancreatic head cancer for better tumor staging.
Pedrazzoli S
Cancer Treat Rev; 2015 Jul; 41(7):577-87. PubMed ID: 26045226
[TBL] [Abstract] [Full Text] [Related]
16. Loss of DAXX and atrX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors.
Marinoni I; Kurrer AS; Vassella E; Dettmer M; Rudolph T; Banz V; Hunger F; Pasquinelli S; Speel EJ; Perren A
Gastroenterology; 2014 Feb; 146(2):453-60.e5. PubMed ID: 24148618
[TBL] [Abstract] [Full Text] [Related]
17. Anatomic resection reduces the recurrence of solitary hepatocellular carcinoma ≤5 cm without macrovascular invasion.
Kudo A; Tanaka S; Ban D; Matsumura S; Irie T; Nakamura N; Arii S
Am J Surg; 2014 Jun; 207(6):863-9. PubMed ID: 24112679
[TBL] [Abstract] [Full Text] [Related]
18. Risk of peritoneal carcinomatosis by endoscopic ultrasound-guided fine needle aspiration for pancreatic cancer.
Ikezawa K; Uehara H; Sakai A; Fukutake N; Imanaka K; Ohkawa K; Tanakura R; Ioka T; Tanaka S; Ishikawa O; Katayama K
J Gastroenterol; 2013 Aug; 48(8):966-72. PubMed ID: 23065024
[TBL] [Abstract] [Full Text] [Related]
19. Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss.
McMillan DC; Watson WS; O'Gorman P; Preston T; Scott HR; McArdle CS
Nutr Cancer; 2001; 39(2):210-3. PubMed ID: 11759282
[TBL] [Abstract] [Full Text] [Related]
